$788K in expenses

Translation to the clinic: accrf supports and coordinates research into treatments most likely to lead to clinical ebenfit for adenoid cystic carcinoma patients. Drug discovery, drug development, preclinical drug screening and correlative studies are crucial to the initiation and optimal conduct of clinical trials.

$476K in expenses

Basic research: accrf supports and coordinates the descriptive and functional studies that identify molecular targets and pathways that permit adenoid cystic carcinoma to progress. By focusing on the mechanisms of action, researchers may discover more quickly the achilles' heel of the disease.